biostudies-otherUnknownDutertre MartinHomo sapienshttps://www.ebi.ac.uk/biostudies/studies/S-ECPF-GEOD-53474EurocanPlatformAlternative 3’-terminal exons, which use intronic polyadenylation sites, are generally unconserved and lowly expressed, while the main gene products end in the last exon of genes. In this study, we discover a class of human genes, where the last exon appeared recently during evolution, and the major gene product uses an alternative 3’-terminal exon corresponding to the ancestral last exon of the gene. This novel class of alternative 3’-terminal exons are down-regulated on a large scale by doxorubicin, a cytostatic drug targeting topoisomerase II, and play a role in cell cycle regulation, including centromere-kinetochore assembly. The RNA-binding protein, HuR/ELAVL1 is a major regulator of this specific set of alternative 3’-terminal exons. HuR binding to the alternative 3’-terminal exon inbiostudies-othertranscription profiling by arrayEurocanPlatformCombe EmmanuelPolay Espinoza MicaelaDutertre MartinZahra Chakrama FatimaDesmet François-OlivierMortada HusseinGratadou LiseAuboeuf DidierfalseA novel class of alternative 3?-terminal exons is involved in cell-cycle regulation by topoisomerase inhibitorsAlternative 3’-terminal exons, which use intronic polyadenylation sites, are generally unconserved and lowly expressed, while the main gene products end in the last exon of genes. In this study, we discover a class of human genes, where the last exon appeared recently during evolution, and the major gene product uses an alternative 3’-terminal exon corresponding to the ancestral last exon of the gene. This novel class of alternative 3’-terminal exons are down-regulated on a large scale by doxorubicin, a cytostatic drug targeting topoisomerase II, and play a role in cell cycle regulation, including centromere-kinetochore assembly. The RNA-binding protein, HuR/ELAVL1 is a major regulator of this specific set of alternative 3’-terminal exons. HuR binding to the alternative 3’-terminal exon in2016-04-14T14:33:26Z2016-04-14T14:33:26Z2016-04-14T14:33:26ZS-ECPF-GEOD-53474GSE53474E-GEOD-53474EFO_0000305EFO_0000322E-GEOD-53474